The Brandi Law Firm has extensive experience in drug litigation. Thomas Brandi and John Hornbeck have over 50 years of trial experience successfully taking on defective drug companies on behalf of injured people. They have successfully represented clients injured from numerous drugs and devices including Rezulin, Phen-fen, L Tryptophan, Felbatol, breast implants, and the Dalkon Shield IUD. John Hornbeck has served on the MDL committees establishing liability for Rezulin, Phen-fen, and L-Tryptophan. The Brandi Law Firm has a team of attorneys, investigators, doctors and nurses investigating Vioxx cases.
If we represent you, Mr. Brandi and Mr. Hornbeck will be your trial attorneys. On November 13, 2004 Mr. Brandi was named Trial Lawyer of the Year for the State of California by the Consumers Attorneys of California. He has been a finalist for Trial Lawyer of the Year for the Trial Lawyers of Public Justice (2004), Consumer Attorneys of California (2002) and San Francisco Trial Lawyers Association (1999, 2001). If you consult with any counsel, you should ask who will be working on your case, and if the case goes to trial, the identity of the trial attorneys and their courtroom trial experience.
WHAT IS VIOXX?
The prescription drug Vioxx, manufactured by Merck & Co., is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by the FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms. Vioxx was later approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children. It became a widely prescribed medication for the relief of pain caused by arthritis.
WHY WAS VIOXX WITHDRAWN FROM THE MARKETPLACE?
The FDA was informed by Merck & Co., on September 27, 2004, that the Data Safety Monitoring Board for an ongoing long-term study of Vioxx (APPROVe) had recommended that the study be stopped early for safety reasons. The study was being conducted in patients at risk for developing recurrent colon polyps. The study showed an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx compared to placebo, particularly those who had been taking the drug for longer than 18 months. Based on this new safety information, Merck and FDA officials met the next day, September 28, 2004, and during that meeting the FDA was informed that Merck was voluntarily withdrawing Vioxx from the market place.
WHY WOULD I NEED AN ATTORNEY?
If you or your loved one suffered a "cardiovascular event" (including heart attack and stroke) while taking Vioxx, there may be a causal link between the two. If Vioxx caused the event, you are entitled to seek financial relief under personal injury and defective product liability laws.
At The Brandi Law Firm, our defective drug litigation attorneys have extensive experience representing victims of injuries and people who have lost loved ones as a result of defective medication. John Hornbeck was a key member of the MDL Committees establishing product defect in Fen-Phen Rezulin and L-tryptophan. If you think you may have suffered an injury or lost a loved one as a result of taking Vioxx, contact us immediately. We will schedule a FREE CONSULTATION where you will meet with a knowledgeable defective drug lawyer.
We serve clients in the San Francisco Bay Area and throughout California, including the cities of Los Angeles, San Diego, Sacramento, San Jose, Irvine, and Ventura, as well as San Mateo, Alameda, San Luis Obispo, Mendocino, Solano, Contra Costa, Marin, Orange, and Santa Clara Counties.